methyl 2-oxo-2-(1H-pyrrolo[2,3-c]pyridin-3-yl)acetate | 357263-51-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并吡啶类
• 英文名称: methyl 2-oxo-2-(1H-pyrrolo[2,3-c]pyridin-3-yl)acetate
• 英文别名: methyl α-oxo-6-azaindole-3-acetate；methyl (6-azaindol-3-yl)-oxoacetate；methyl (6-azaindol-3-yl)oxoacetate
• CAS: 357263-51-5
• 化学式: C₁₀H₈N₂O₃
• 分子量: 204.185
• InChiKey: VCJJWOALTIARTF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  72
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 2-oxo-2-(1H-pyrrolo[2,3-c]pyridin-3-yl)acetate 在 水 、 potassium carbonate 作用下， 以 甲醇 为溶剂， 生成 2-oxo-2-(1H-pyrrolo[2,3-c]pyridin-3-yl)acetic acid
  参考文献：
  名称：

  Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects

  摘要：

  Azaindole derivatives derived from the screening lead 1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione (1) were prepared and characterized to assess their potential as inhibitors of HIV-1 attachment. Systematic replacement of each of the unfused carbon atoms in the phenyl ring of the indole moiety by a nitrogen atom provided four different azaindole derivatives that displayed it clear SAR for antiviral activity and all of which displayed marked improvements in pharmaceutical properties. Optimization of these azaindole leads resulted in the identification of two compounds that were advanced to clinical studies: (R)-1-(4-benzoyl-2-methylpiperazin-1-yl)-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione (BMS-377806, 3) and 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043, 4). In a preliminary clinical study, 4 administered as monotherapy for 8 days, reduced viremia in HIV-1-infected Subjects, providing proof of concept for this mechanistic class.

  DOI：

  10.1021/jm900843g
• 作为产物：
  描述：

  甲基戊酰氯 、 6-氮杂吲哚 在 aluminum (III) chloride 作用下， 以 硝基甲烷 、 二氯甲烷 为溶剂， 以84 %的产率得到methyl 2-oxo-2-(1H-pyrrolo[2,3-c]pyridin-3-yl)acetate
  参考文献：
  名称：

  荧光胍-氮杂咔唑用于水中氧阴离子结合

  摘要：

  含氧阴离子，如羧酸根、磷酸根和硫酸根，在化学和生物学中发挥着重要作用，并且在细胞表面大量存在。我们报告了合理设计的含胍含氧阴离子结合剂 1-胍基-8-氨基-2,7-二氮杂咔唑 (GADAC) 的合成和性能。GADAC 在纯水中与羧酸盐、磷酸盐和硫酸盐结合，亲和力分别为 3.6 × 10 4、1.1 × 10 3和 4.2 × 10 3 M –1。与 2-氮杂咔唑（一种能使蝎子发出荧光的天然产物）一样，GADAC 在水中也会发出荧光（λabs = 356 nm，λ em = 403 nm，ε = 13,400 M –1 cm –1）。GADAC 的量子产率对 pH 值敏感，由于氨基吡啶部分的质子化，从 pH 7.4 时的 Φ = 0.12 增加到 pH 4.0 时的 Φ = 0.53。在低微摩尔浓度的 DAPI 通道中可以检测到活人黑色素瘤细胞对 GADAC 的摄取。其特性使 GADAC 成

  DOI：

  10.1021/acs.joc.3c00982

文献信息

• Antiviral azaindole derivatives
  申请人：——

  公开号：US20030181463A1

  公开（公告）日：2003-09-25

  The present invention is directed to a series of chemical entities that express HIV-1 inhibitory activities.

  本发明涉及一系列具有HIV-1抑制活性的化学实体。
• COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES
  申请人：Wang Tao

  公开号：US20080119480A1

  公开（公告）日：2008-05-22

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  该发明提供了具有药物和生物影响性质的化合物，它们的制药组合物和使用方法。特别地，该发明涉及氮杂吲哌酮乙酰基哌嗪衍生物。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染药物、免疫调节剂或HIV进入抑制剂联合使用。更具体地，本发明涉及治疗HIV和艾滋病。
• PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS
  申请人：Wang Tao

  公开号：US20100093752A1

  公开（公告）日：2010-04-15

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  本发明提供了具有药物和生物影响性质的化合物，它们的药物组合物和使用方法。特别是，本发明涉及氮杂吲哚氧乙酰哌嗪衍生物。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染药物、免疫调节剂或HIV进入抑制剂结合使用。更具体地，本发明涉及治疗HIV和艾滋病。
• PRODRUGS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES
  申请人：Bristol-Myers Squibb Company

  公开号：US20150329543A1

  公开（公告）日：2015-11-19

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  本发明提供具有药物和生物影响特性的化合物，其制药组合物和使用方法。特别地，本发明涉及氮杂吲哚氧乙酰基哌嗪衍生物。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染剂、免疫调节剂或HIV进入抑制剂联合使用。更具体地，本发明涉及治疗HIV和艾滋病。
• SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20160207918A1

  公开（公告）日：2016-07-21

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives having the Formula I: wherein Q is These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  本发明提供具有药物和生物影响性质的化合物，它们的制药组合物和使用方法。特别地，本发明涉及具有式I的氮杂吲哚氧乙酰基哌嗪衍生物，其中Q为。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染药物、免疫调节剂或HIV进入抑制剂联合使用。更具体地，本发明涉及治疗HIV和艾滋病。